Matches in Wikidata for { <http://www.wikidata.org/entity/Q57808391> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q57808391 description "article" @default.
- Q57808391 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57808391 description "wetenschappelijk artikel" @default.
- Q57808391 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57808391 name "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 name "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 type Item @default.
- Q57808391 label "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 label "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 prefLabel "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 prefLabel "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 P1433 Q57808391-A33C53BF-76AD-459C-8835-C0E35704643D @default.
- Q57808391 P1476 Q57808391-CB4D6C37-C1EB-4978-ACA6-3A560BEC2806 @default.
- Q57808391 P2093 Q57808391-152AAD93-AB8B-4E52-845A-0F65EDABB344 @default.
- Q57808391 P2093 Q57808391-39AE1F7F-D710-4145-9509-2729CB589020 @default.
- Q57808391 P2093 Q57808391-5EC8B063-E160-47CC-918E-B9D9C9136014 @default.
- Q57808391 P2093 Q57808391-86CE678F-80BA-47C5-853C-83BF4D310268 @default.
- Q57808391 P2093 Q57808391-BE37EDD0-FB98-4C44-A0A4-90F7AED3E09A @default.
- Q57808391 P2093 Q57808391-D38AFE7D-5EBB-430D-9AA8-EA9970EF9EDB @default.
- Q57808391 P2093 Q57808391-D50447B6-5414-433E-AFB6-664C89E0EC72 @default.
- Q57808391 P304 Q57808391-2F9E721E-E85F-4822-9C37-2894B782F690 @default.
- Q57808391 P31 Q57808391-7A4D70D8-D0A0-4471-943E-38FA9EE9A166 @default.
- Q57808391 P356 Q57808391-4CBB8857-5056-48B7-8138-84E44A669FC4 @default.
- Q57808391 P407 Q57808391-594C969B-F02C-4A39-941F-EBF18DC13ECA @default.
- Q57808391 P478 Q57808391-5ECFB27E-EFEA-4C8E-9E16-7095CFF26E9D @default.
- Q57808391 P50 Q57808391-B4D83A69-90CD-4658-858A-9EB9ACC2FECE @default.
- Q57808391 P577 Q57808391-0CF2ABE2-C110-4B61-B8C0-FC34AF7212F9 @default.
- Q57808391 P698 Q57808391-68B908BB-6D98-44CC-80FC-5D5EF20F4F63 @default.
- Q57808391 P356 J.JOCN.2018.09.012 @default.
- Q57808391 P698 30348586 @default.
- Q57808391 P1433 Q6294963 @default.
- Q57808391 P1476 "Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study" @default.
- Q57808391 P2093 "Aaron E Miller" @default.
- Q57808391 P2093 "Karthinathan Thangavelu" @default.
- Q57808391 P2093 "Mark S Freedman" @default.
- Q57808391 P2093 "Myriam Benamor" @default.
- Q57808391 P2093 "Philippe Truffinet" @default.
- Q57808391 P2093 "Richard Macdonell" @default.
- Q57808391 P2093 "Xianhao Xu" @default.
- Q57808391 P304 "229-231" @default.
- Q57808391 P31 Q13442814 @default.
- Q57808391 P356 "10.1016/J.JOCN.2018.09.012" @default.
- Q57808391 P407 Q1860 @default.
- Q57808391 P478 "59" @default.
- Q57808391 P50 Q66904917 @default.
- Q57808391 P577 "2018-10-20T00:00:00Z" @default.
- Q57808391 P698 "30348586" @default.